Global Stem Cell Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Technology;

Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cells and Others.

By Application;

Regenerative Medicine, Neurological Disorders, Orthopaedic Disorders, Oncology, Diabetes, Injuries & Wounds, Cardiovascular Disorders and Others.

By Cell Type;

Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy and Syngeneic Stem Cell Therapy.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn234027230 Published Date: June, 2024 Updated Date: July, 2024


Global Stem Cell Therapeutics Market (USD Million), 2020 - 2030

In the year 2023, the Global Stem Cell Therapeutics Market was valued at USD 308.00 million. The size of this market is expected to increase to USD 941.32 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 17.3%.

The global stem cell therapeutics market has witnessed significant growth in recent years, driven by advancements in medical research and technology. Stem cell therapy, a promising field within regenerative medicine, holds immense potential for treating a variety of diseases and injuries by harnessing the body's natural healing capabilities. Stem cells, characterized by their ability to differentiate into various cell types, offer hope for addressing conditions ranging from neurodegenerative disorders to cardiovascular diseases.

Key factors propelling the growth of the global stem cell therapeutics market include increasing investment in research and development activities, rising prevalence of chronic diseases, and growing awareness about the therapeutic potential of stem cells. Collaborations between academic institutions, biotechnology companies, and pharmaceutical firms are fostering innovation in stem cell research, leading to the development of novel therapies and treatment modalities. Favorable government initiatives and regulatory support for stem cell research are contributing to the expansion of the market landscape.

The promising outlook, challenges such as ethical considerations, regulatory complexities, and high treatment costs remain significant barriers to widespread adoption of stem cell therapies. Ongoing efforts to address these challenges through improved regulations, ethical guidelines, and technological advancements are expected to drive further growth in the global stem cell therapeutics market. As research continues to unravel the full potential of stem cells in medical applications, the market is poised for continued expansion, offering new hope for patients and healthcare providers alike.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Technology
    2. Market Snapshot, By Application
    3. Market Snapshot, By Cell Type
    4. Market Snapshot, By Region
  4. Global Stem Cell Therapeutics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Research Investment
        2. Disease Prevalence
        3. Therapeutic Potential
        4. Collaboration Innovation
      2. Restraints
        1. Ethical considerations
        2. Regulatory complexities
        3. Treatment costs
        4. Safety concerns
      3. Opportunities
        1. Technological Innovation
        2. Government Support
        3. Regulatory Streamlining
        4. Market Expansion
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Stem Cell Therapeutics Market, By Technology, 2020 - 2030 (USD Million)
      1. Adult Stem Cells
      2. Human Embryonic Cells
      3. Pluripotent Stem Cells
      4. Others
    2. Global Stem Cell Therapeutics Market, By Application, 2020 - 2030 (USD Million)
      1. Regenerative Medicine
      2. Neurological Disorders
      3. Orthopaedic Disorders
      4. Oncology
      5. Diabetes
      6. Injuries & Wounds
      7. Cardiovascular Disorders
      8. Others
    3. Global Stem Cell Therapeutics Market, By Cell Type, 2020 - 2030 (USD Million)
      1. Allogeneic Stem Cell Therapy
      2. Autologous Stem Cell Therapy
      3. Syngeneic Stem Cell Therapy
    4. Global Stem Cell Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Vericel Corporation
      2. Astellas Pharma
      3. Athersys
      4. Fate Therapeutics Inc.
      5. Cytori Therapeutics, Inc.
      6. Geron Corporation
      7. Thermo Fisher Scientific, Inc.
      8. Pluristem Therapeutics Inc.
      9. Viacyte, Inc.
      10. Osiris Therapeutics, Inc.
      11. Capricor Therapeutics Inc.
  7. Analyst Views
  8. Future Outlook of the Market